These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17876335

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments.
    He SL, Shen J, Sun XJ, Zhu XJ, Liu LM, Dong JC.
    World J Gastroenterol; 2013 Jul 28; 19(28):4552-8. PubMed ID: 23901232
    [Abstract] [Full Text] [Related]

  • 24. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
    Liu Y, Yue H, Xu S, Wang F, Ma N, Li K, Qiao L, Wang J.
    Int J Clin Oncol; 2015 Oct 28; 20(5):952-9. PubMed ID: 25712158
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma.
    Park JW, Finn RS, Kim JS, Karwal M, Li RK, Ismail F, Thomas M, Harris R, Baudelet C, Walters I, Raoul JL.
    Clin Cancer Res; 2011 Apr 01; 17(7):1973-83. PubMed ID: 21349999
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma.
    Shim JH, Park JW, Nam BH, Lee WJ, Kim CM.
    Cancer Chemother Pharmacol; 2009 Feb 01; 63(3):459-67. PubMed ID: 18437384
    [Abstract] [Full Text] [Related]

  • 31. [Oxaliplatin plus capecitabine for advanced gastric cancer: report of 38 cases].
    Guan M, Zhang L, Zhao L, Bai CM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug 01; 32(4):407-11. PubMed ID: 20868599
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients.
    Berretta M, Lleshi A, Di Benedetto F, Bearz A, Spina M, Tirelli U.
    Ann Oncol; 2006 Jul 01; 17(7):1176-7. PubMed ID: 16798837
    [No Abstract] [Full Text] [Related]

  • 34. [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer].
    Min N, He BF, Zhang LS, Liao H, Jia YZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 01; 30(3):599-601. PubMed ID: 20335149
    [Abstract] [Full Text] [Related]

  • 35. Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.
    Zhu AX, Blaszkowsky LS, Ryan DP, Clark JW, Muzikansky A, Horgan K, Sheehan S, Hale KE, Enzinger PC, Bhargava P, Stuart K.
    J Clin Oncol; 2006 Apr 20; 24(12):1898-903. PubMed ID: 16622265
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.
    Brandi G, de Rosa F, Agostini V, di Girolamo S, Andreone P, Bolondi L, Serra C, Sama C, Golfieri R, Gramenzi A, Cucchetti A, Pinna AD, Trevisani F, Biasco G, Italian Liver Cancer (ITA.LI.CA) Group.
    Oncologist; 2013 Apr 20; 18(12):1256-7. PubMed ID: 24232581
    [Abstract] [Full Text] [Related]

  • 38. Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy.
    Shao YY, Huang CC, Lin SD, Hsu CH, Cheng AL.
    Clin Cancer Res; 2012 Jul 15; 18(14):3992-7. PubMed ID: 22623732
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.
    Patrikidou A, Sinapi I, Regnault H, Fayard F, Bouattour M, Fartoux L, Faivre S, Malka D, Ducreux M, Boige V.
    Invest New Drugs; 2014 Oct 15; 32(5):1028-35. PubMed ID: 24748335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.